Nicholas D. James

Also affiliated with Institute of Cancer Research, Royal Marsden Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Accumulation of copy number alterations and clinical progression across advanced prostate cancer”.

Accumulation of copy number alterations and clinical progression across advanced prostate cancer

Genome Medicine(2022)10.1186/s13073-022-01080-4

N/A

0.889DataRank · unranked

30 citations

Stefanie Friedrich, Chris Brawley, Larissa Mendes, Marina Parry, Adnan Ali +28 more

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

The Lancet Digital Health(2025)10.1016/j.landig.2025.100885

N/A

0.573DataRank · unranked

17 citations

Larissa Mendes, Vinnie Y.T. Liu, Emily Grist, Songwan Joun, Rikiya Yamashita +35 more

Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.07.014

N/A

0.385DataRank · unranked

12 citations

Amol C. Shetty, Yang Song, Theresa Hodges, Tung Hoang, Zaker Rana +11 more

Transcriptome classification of PTEN inactivation to predict survival benefit from docetaxel at start of androgen deprivation therapy (ADT) for metastatic prostate cancer (PC): An ancillary study of the STAMPEDE trials.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5003

N/A

0.165DataRank · unranked

2 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, J. Proudfoot +15 more

1615P A new prognostic model of overall survival (OS) in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC)

Annals of Oncology(2024)10.1016/j.annonc.2024.08.1696

N/A

0DataRank · unranked

0 citations

Bingcheng Luo, Shuo Guo, Larysa Rydzewska, Peter J. Godolphin, M.K. Parmar +6 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Journal of Clinical Oncology(2025)10.1200/jco-25-01608

N/A

0DataRank · unranked

16 citations

Matthew D. Galsky, Nazlı Dizman, David H. Aggen, Neeraj Agarwal, Hikmat Al‐Ahmadie +39 more

Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group

Journal of bone oncology(2020)10.1016/j.jbo.2020.100311

N/A

0DataRank · unranked

73 citations

Catherine Handforth, Juliet Compston, William Cross, Nigel J. Parr, Peter Selby +11 more

Adherence to Dietary Change Using mHealth Approaches in Adults: Systematic Review Protocol and PRISMA Flow Diagram

Journal of the Academy of Nutrition and Dietetics(2025)10.1016/j.jand.2025.06.328

N/A

0DataRank · unranked

0 citations

Nicholas D. James, B. Haaga, C. Taucer, Johan De Mey

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.04.515

N/A

0DataRank · unranked

28 citations

Amol C. Shetty, Alex Hakansson, Kim Van der Eecken, Yang Song, Y. Liu +27 more

Assessing PSA levels as prognostic of overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5070

N/A

0DataRank · unranked

8 citations

Akash Roy, Siyuan S Guo, Larysa Rydzewska, Peter J. Godolphin, Maha Hussain +15 more

Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer

Journal of Clinical Oncology(2024)10.1200/jco.23.01535

N/A

0DataRank · unranked

29 citations

Akash Roy, Larysa Rydzewska, Siyuan Guo, Peter J. Godolphin, Maha Hussain +15 more